source
- Veradermics keeps ‘momentum going’ as baldness drug helps women with hair lossThe Phase 2 data exceeded expectations, lifting company shares as high as nearly $130 apiece and building the case for what may be the first pill specifically approved for female pattern hair loss.BioPharma Dive · 14d ago↗ source
- Merck wins first approval of a PCSK9 cholesterol pillThe speedy clearance of Lipfendra is an important milestone for Merck and the result of a controversial voucher program put in place by former FDA commissioner Marty Makary.BioPharma Dive · 14d ago↗ source
- Convenience Kit Recall: B. Braun Medical, Inc. Removes Spinal Anesthesia Kits Containing Huons Bupivacaine Hydrochloride in Dextrose Injection, USPB. Braun is removing affected convenience kits containing recalled Bupivacaine Hydrochloride in Dextrose Injection components